SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Schedule 13G
Under the Securities Exchange Act of 1934
(Amendment No. 5)*
Integra LifeSciences Holdings Corporation
(Name of Issuer)
Common stock, $.01 par value
(Title of Class of Securities)
457985208
(CUSIP Number)
December 31, 2007
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
[ ] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[X] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class
of securities, and for any subsequent amendment containing information
which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of
that section of the Act but shall be subject to all other provisions of
the Act (however, see the Notes).
Page 2 of 11 Pages
- ---------------------
CUSIP No. 457985208 13G
- ---------------------
- ------- -----------------------------------------------------------------------
1 NAME OF REPORTING PERSON: Richard E. Caruso, Ph.D.
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (entities only):
- ------- -----------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a) |X|
(b) |_|
- ------- -----------------------------------------------------------------------
3 SEC USE ONLY
- ------- -----------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- -------------------------------------------- ---- -----------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES 78,071 shares*
---- -----------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY 6,633,543*
---- -----------------------------
EACH 7 SOLE DISPOSITIVE POWER
78,071*
REPORTING PERSON ---- -----------------------------
8 SHARED DISPOSITIVE POWER
WITH:
6,633,543*
- -------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
6,711,614 shares*
- ------- -----------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(See Instructions)
- ------ ------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
25.5%*
- ------- -----------------------------------------------------------------------
12 TYPE OF REPORTING PERSON (See Instructions)
IN
- ------- -----------------------------------------------------------------------
*Includes 55,000 shares of common stock that may be acquired
upon exercise of options as of or within 60 days of February
1, 2008. Dr. Caruso disclaims beneficial ownership of the
shares owned by Tru St Partnership LP, Provco Leasing
Corporation and The Uncommon Individual Foundation as
described in this Schedule 13G (Amendment No. 5) except to the
extent of his pecuniary interest therein.
Page 3 of 11 Pages
- ---------------------
CUSIP No. 457985208 13G
- ---------------------
- ------- -----------------------------------------------------------------------
1 NAME OF REPORTING PERSON: Tru St Partnership LP
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (entities only):
- ------- -----------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a) |X|
(b) |_|
- ------- -----------------------------------------------------------------------
3 SEC USE ONLY
- ------- -----------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Pennsylvania
- -------------------------------------------- ---- -----------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES 0
---- -----------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY 6,591,205 shares
---- -----------------------------
EACH 7 SOLE DISPOSITIVE POWER
0
REPORTING PERSON ---- ----------------------------
8 SHARED DISPOSITIVE POWER
WITH:
6,591,205 shares
- ------- -----------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
6,591,205 shares
- ------- -----------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(See Instructions)
- ------- -----------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
25.0%
- ------- -----------------------------------------------------------------------
12 TYPE OF REPORTING PERSON (See Instructions)
PN
- ------- -----------------------------------------------------------------------
Page 4 of 11 Pages
- ---------------------
CUSIP No. 457985208 13G
- ---------------------
- ------- -----------------------------------------------------------------------
1 NAME OF REPORTING PERSON: Provco Leasing Corporation
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (entities only):
- ------- -----------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a) |X|
(b) |_|
- ------- -----------------------------------------------------------------------
3 SEC USE ONLY
- ------- -----------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- -------------------------------------------- ---- -----------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES 0
---- -----------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY 6,614,543 shares
---- -----------------------------
EACH 7 SOLE DISPOSITIVE POWER
0
REPORTING PERSON ---- -----------------------------
8 SHARED DISPOSITIVE POWER
WITH:
6,614,543 shares
- ------- -----------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
6,614,543 shares
- ------- -----------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(See Instructions)
- ------- -----------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
25.1%
- ------- -----------------------------------------------------------------------
12 TYPE OF REPORTING PERSON (See Instructions)
CO
- ------- -----------------------------------------------------------------------
Page 5 of 11 Pages
- ---------------------
CUSIP No. 457985208 13G
- ---------------------
- ------- -----------------------------------------------------------------------
1 NAME OF REPORTING PERSON: The Uncommon Individual Foundation
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (entities only):
- ------- -----------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a) |X|
(b) |_|
- ------- -----------------------------------------------------------------------
3 SEC USE ONLY
- ------- -----------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Pennsylvania
- -------------------------------------------- ---- -----------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES 0
---- -----------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY 19,000 shares
---- -----------------------------
EACH 7 SOLE DISPOSITIVE POWER
0
REPORTING PERSON ---- -----------------------------
8 SHARED DISPOSITIVE POWER
WITH:
19,000 shares
- ------- -----------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
19,000 shares
- ------- -----------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(See Instructions)
- ------- -----------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0.072%
- ------- -----------------------------------------------------------------------
12 TYPE OF REPORTING PERSON (See Instructions)
CO
- ------- -----------------------------------------------------------------------
Page 6 of 11 Pages
Item 1.
(a) Name of Issuer: Integra LifeSciences Holdings Corporation
(b) Address of Issuer's Principal Executive Offices: 311
Enterprise Drive, Plainsboro, New Jersey 08536
Item 2.
(a) Name of Person Filing: See (c) below.
(b) Address of Principal Business Office or, if none, Residence: See
(c) below.
(c) Citizenship:
Richard E. Caruso Ph.D.
795 East Lancaster Ave., Suite 200
Villanova, Pennsylvania 19085
United States citizen
Tru St Partnership LP
795 East Lancaster Ave., Suite 200
Villanova, Pennsylvania 19085
Pennsylvania limited partnership
Provco Leasing Corporation
209B Baynard Building
3411 Silverside Road
Wilmington, Delaware 19810
Delaware corporation
The Uncommon Individual Foundation
795 East Lancaster Ave., Suite 204
Villanova, Pennsylvania 19085
Pennsylvania corporation
(d) Title of Class of Securities: common stock, $.01 par value.
(e) CUSIP Number: 457985208
Item 3. Not applicable.
Item 4. Ownership: Provide the following information regarding the
aggregate number and percentage of the class of securities of
the issuer identified in Item 1.
(a) Amount beneficially owned: As of December 31, 2007, Dr.
Caruso may be deemed the beneficial owner of 6,711,614
shares of common stock. He individually holds 23,071
shares and holds options to purchase 55,000 shares of
common stock that are exercisable within 60 days of
February 1, 2008. Tru St Partnership LP ("Tru St") may be
deemed the beneficial owner of 6,591,205 shares of common
stock. Dr. Caruso is the president and sole director of
Provco Leasing Corporation ("Provco Leasing"). Provco
Page 7 of 11 Pages
Leasing is the corporate general partner of Tru St.
Provco Leasing is also the beneficial owner of 23,338
shares of common stock. The Uncommon Individual
Foundation is the beneficial owner of 19,000 shares of
common stock. Dr. Caruso is the founder and chief
executive officer of The Uncommon Individual Foundation.
Dr. Caruso disclaims beneficial ownership of shares held
by Tru St, Provco Leasing and The Uncommon Individual
Foundation except to the extent of his pecuniary interest
therein.
(b) Percent of Class: Based on 26,363,053 shares of the
Issuer's common stock outstanding as of November 5, 2007
as reported in the Issuer's Form 10-Q for the quarter
ended September 20, 2007: Dr. Caruso may be deemed the
beneficial owner of 25.5% of the Issuer's common stock;
Tru St, may be deemed the beneficial owner of 25.0% of the
Issuer's common stock; Provco Leasing may be deemed the
beneficial owner of 25.1% of the Issuer's common stock and
The Uncommon Individual Foundation may be deemed the
beneficial owner of 0.072% of the Issuer's common stock.
(c) The Reporting Persons have the power to vote or dispose of
the number of shares as follows:
(i) Sole power to vote or direct the vote. Dr.
Caruso may be deemed to have sole power to
vote or direct the vote of 78,071 shares of
common stock based on his ownership of
23,071 shares and options to purchase 55,000
shares of common stock that are exercisable
within 60 days of February 1, 2008.
(ii) Shared power to vote or direct the vote. Dr.
Caruso, Tru St, Provco Leasing and The
Uncommon Individual Foundation may be deemed
to share the power to vote or direct the
vote with respect to 6,633,543 shares of
common stock. Dr. Caruso and Tru St may be
deemed to share the power to vote or direct
the vote with respect to 6,591,205 shares of
common stock. Dr. Caruso and Provco Leasing
may be deemed to share the power to vote or
direct the vote with respect to 6,614,543
shares of common stock. Dr. Caruso and The
Uncommon Individual Foundation may be deemed
to share the power to vote or direct the
vote with respect to 19,000 shares of common
stock.
(iii) Sole power to dispose or direct the
disposition. Dr. Caruso has sole power to
dispose or control the disposition of 78,071
shares of common stock based on his
ownership of 23,071 shares and options to
purchase 55,000 shares of common stock that
are exercisable within 60 days of February
1, 2008.
(iv) Shared power to dispose or direct the
disposition. Dr. Caruso, Tru St Provco
Leasing and The Uncommon Individual
Foundation may be deemed to have shared
power to dispose of or shared power to
direct the disposition of 6,633,543 shares
of common stock. Dr. Caruso and Tru St may
be deemed to have shared power to dispose of
or shared power to direct the disposition of
6,591,205 shares of common stock. Dr.
Caruso and Provco Leasing may be deemed to
have shared power to dispose of or shared
power to direct the disposition of 6,614,543
shares of common stock. Dr. Caruso and The
Uncommon Individual Foundation may be deemed
to have shared power to dispose of or direct
the disposition of 19,000 shares of common
stock.
Page 8 of 11 Pages
Item 5. Ownership of Five Percent or less of a Class:
Not applicable.
Item 6. Ownership of More Than Five Percent on Behalf of Another
Person:
Not applicable
Item 7. Identification and Classification of the Subsidiary which
Acquired the Security Reported on by the Parent Holding
Company:
Not applicable
Item 8. Identification and Classification of Members of the Group:
Exhibit A attached hereto identifies each member of the group
filing this Schedule 13G/A pursuant to Rule 13d-1(c).
Item 9. Notice of Dissolution of Group:
Not applicable
Item 10. Certification: Not applicable.
Signature
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Date: February 5, 2008 /s/ Richard E. Caruso, Ph.D.
------------------------------
Richard E. Caruso, Ph.D.
TRU ST PARTNERSHIP LP
PROVCO LEASING CORPORATION, GP
By: /s/ Richard E. Caruso, Ph.D.
----------------------------
Its: President
PROVCO LEASING CORPORATION
By: /s/ Richard E. Caruso, Ph.D.
----------------------------
Its: President
THE UNCOMMON INDIVIDUAL FOUNDATION
By: /s/ Richard E. Caruso, Ph.D.
----------------------------
Its: President
Page 9 of 11 Pages
Exhibit Index
Exhibit Title Page No.
Exhibit A Group Members 12
Exhibit B Joint Filing Agreement 13
Page 10 of 11 Pages
EXHIBIT A
Group Members
Richard E. Caruso, Ph.D.
Tru St Partnership LP
Provco Leasing Corporation
The Uncommon Individual Foundation
Page 11 of 11 Pages
EXHIBIT B
Joint Filing Agreement
In accordance with Rule 13d-1(k) under the Securities Exchange Act of
1934, as amended, the persons named below agree to the joint filing on behalf of
each of them of a Statement on Schedule 13G/A (including amendments thereto)
with respect to the common stock, par value $.01 per share of Integra
LifeSciences Holdings Corporation, and further agree that this Joint Filing
Agreement be included as Exhibit to such joint filings. In evidence thereof, the
undersigned, being duly authorized, have executed this Joint Filing Agreement
this fifth day of February 2008.
TRU ST PARTNERSHIP LP
PROVOCO LEASING CORPORATION, GP
By: /s/ Richard E. Caruos, Ph.D. By: /s/ Richard E. Caruso, Ph.D.
------------------------ ----------------------------
Its: President Richard E. Caruso, Ph.D.
PROVCO LEASING CORPORATION
By: /s/ Richard E. Caruso, Ph.D.
------------------------
Its: President
THE UNCOMMON INDIVIDUAL FOUNDATION
By: /s/ Richard E. Caruso, Ph.D.
----------------------------
Its: President